Founders Financial Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $272K | Buy |
11,306
+125
| +1% | +$3.27K | 0.01% | 485 |
|
|
2026
Q1 | $304K | Sell |
11,181
-326
| -3% | -$8.68K | 0.02% | 449 |
|
|
2025
Q4 | $287K | Buy |
11,507
+1,459
| +15% | +$36.8K | 0.02% | 482 |
|
|
2025
Q3 | $256K | Sell |
10,048
-2,108
| -17% | -$52K | 0.02% | 443 |
|
|
2025
Q2 | $295K | Sell |
12,156
-1,882
| -13% | -$43.9K | 0.02% | 416 |
|
|
2025
Q1 | $324K | Buy |
14,038
+2,263
| +19% | +$59.2K | 0.03% | 382 |
|
|
2024
Q4 | $312K | Sell |
11,775
-1,759
| -13% | -$47.7K | 0.03% | 369 |
|
|
2024
Q3 | $392K | Sell |
13,534
-2,880
| -18% | -$84K | 0.04% | 305 |
|
|
2024
Q2 | $459K | Buy |
16,414
+2,558
| +18% | +$70.4K | 0.04% | 298 |
|
|
2024
Q1 | $385K | Sell |
13,856
-51,071
| -79% | -$1.42M | 0.04% | 290 |
|
|
2023
Q4 | $1.87M | Sell |
64,927
-760
| -1% | -$23K | 0.21% | 94 |
|
|
2023
Q3 | $2.18M | Buy |
65,687
+33,330
| +103% | +$1.18M | 0.28% | 72 |
|
|
2023
Q2 | $1.19M | Buy |
32,357
+2,298
| +8% | +$89.4K | 0.16% | 125 |
|
|
2023
Q1 | $1.23M | Buy |
30,059
+905
| +3% | +$39.1K | 0.18% | 113 |
|
|
2022
Q4 | $1.49M | Buy |
29,154
+2,101
| +8% | +$101K | 0.24% | 90 |
|
|
2022
Q3 | $1.18M | Sell |
27,053
-223
| -0.8% | -$10.8K | 0.21% | 99 |
|
|
2022
Q2 | $1.43M | Buy |
27,276
+1,173
| +4% | +$59.8K | 0.28% | 75 |
|
|
2022
Q1 | $1.35M | Buy |
26,103
+739
| +3% | +$38.3K | 0.24% | 89 |
|
|
2021
Q4 | $1.5M | Buy |
25,364
+447
| +2% | +$22.1K | 0.27% | 79 |
|
|
2021
Q3 | $1.07M | Buy |
24,917
+550
| +2% | +$24.4K | 0.22% | 98 |
|
|
2021
Q2 | $954K | Buy |
24,367
+1,469
| +6% | +$57.1K | 0.19% | 110 |
|
|
2021
Q1 | $830K | Buy |
22,898
+1,520
| +7% | +$54K | 0.19% | 108 |
|
|
2020
Q4 | $787K | Buy |
21,378
+5,729
| +37% | +$210K | 0.19% | 99 |
|
|
2020
Q3 | $545K | Sell |
15,649
-1,461
| -9% | -$51.2K | 0.17% | 84 |
|
|
2020
Q2 | $546K | Buy |
17,110
+4,998
| +41% | +$170K | 0.18% | 95 |
|
|
2020
Q1 | $375K | Buy |
12,112
+1,912
| +19% | +$65.2K | 0.14% | 83 |
|
|
2019
Q4 | $379K | Buy |
10,200
+1,668
| +20% | +$59.4K | 0.13% | 87 |
|
|
2019
Q3 | $291K | Buy |
8,532
+1,414
| +20% | +$51.4K | 0.09% | 107 |
|
|
2019
Q2 | $293K | Buy |
7,118
+389
| +6% | +$15.4K | 0.1% | 101 |
|
|
2019
Q1 | $271K | Buy |
6,729
+1,248
| +23% | +$50K | 0.09% | 101 |
|
|
2018
Q4 | $227K | Buy |
+5,481
| New | +$228K | 0.08% | 96 |
|
Other funds holding PFE
Founders Financial Securities's PFE Position: Q2 2026 in Review
Founders Financial Securities increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $3.27K and bringing the position to 11,306 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #485.
Founders Financial Securities first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.18M in Q3 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Founders Financial Securities held 11,306 shares of Pfizer worth $272K as of Q2 2026.
- Founders Financial Securities bought 125 Pfizer shares in Q2 2026, an estimated $3.27K.
- Pfizer made up 0.01% of Founders Financial Securities's portfolio in Q2 2026, its #485 holding.
- Founders Financial Securities first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Founders Financial Securities's Pfizer position peaked at $2.18M in Q3 2023.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Founders Financial Securities's 13F filing for Q2 2026, filed 31 Jul 2026.